These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21429486)

  • 1. Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis.
    Matorras R; Osuna C; Exposito A; Crisol L; Pijoan JI
    Fertil Steril; 2011 May; 95(6):1937-42, 1942.e1-3. PubMed ID: 21429486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH.
    Matorras R; Diaz T; Corcostegui B; Ramón O; Pijoan JI; Rodriguez-Escudero FJ
    Hum Reprod; 2002 Aug; 17(8):2107-11. PubMed ID: 12151445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
    Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
    Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation.
    Bakas P; Konidaris S; Liapis A; Gregoriou O; Tzanakaki D; Creatsas G
    Fertil Steril; 2011 May; 95(6):2024-8. PubMed ID: 21334613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
    Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor.
    Sagnella F; Moro F; Lanzone A; Tropea A; Martinez D; Capalbo A; Gangale MF; Spadoni V; Morciano A; Apa R
    Fertil Steril; 2011 Feb; 95(2):689-94. PubMed ID: 20869704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A; Erdem M; Atmaca S; Guler I
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Ragni G; Caliari I; Nicolosi AE; Arnoldi M; Somigliana E; Crosignani PG
    Fertil Steril; 2006 Mar; 85(3):619-24. PubMed ID: 16500328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
    Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
    Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
    Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
    Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of Intermediate Follicles. An Independent Risk Factor of Multiple Pregnancies in Intrauterine Insemination Cycles with Recombinant Follicle-Stimulating Hormone.
    Scalici E; Bechoua S; Jimenez C; Astruc K; Sagot P; Hamamah S
    J Reprod Med; 2015; 60(7-8):279-86. PubMed ID: 26380485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa.
    Matorras R; Recio V; Corcóstegui B; Rodríguez-Escudero FJ
    Hum Reprod; 2000 Jun; 15(6):1231-4. PubMed ID: 10831546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial.
    Berker B; Kahraman K; Taskin S; Sukur YE; Sonmezer M; Atabekoglu CS
    Arch Gynecol Obstet; 2011 Dec; 284(6):1561-6. PubMed ID: 21773781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.